Published in Oncol Lett on September 02, 2015
Nrf2 and Notch Signaling in Lung Cancer: Near the Crossroad. Oxid Med Cell Longev (2016) 0.78
Expression of Notch1 and Numb in small cell lung cancer. Oncotarget (2017) 0.75
Prognostic significance of Notch ligands in patients with non-small cell lung cancer. Oncol Lett (2016) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
The canonical Notch signaling pathway: unfolding the activation mechanism. Cell (2009) 14.72
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol (2012) 6.37
The new lung cancer staging system. Chest (2009) 6.30
High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res (2005) 4.61
Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer (2011) 4.12
The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol (2009) 3.34
Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Cancer Res (2007) 2.54
New pathologic classification of lung cancer: relevance for clinical practice and clinical trials. J Clin Oncol (2013) 2.25
Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. Cancer Res (2007) 1.88
Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis. Proc Natl Acad Sci U S A (2002) 1.54
Notch3 signalling promotes tumour growth in colorectal cancer. J Pathol (2011) 1.06
Notch1 is involved in migration and invasion of human breast cancer cells. Oncol Rep (2011) 1.05
Notch3 and HEY-1 as prognostic biomarkers in pancreatic adenocarcinoma. PLoS One (2012) 1.05
Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer. Clin Cancer Res (2011) 1.03
Notch3 overexpression associates with poor prognosis in human non-small-cell lung cancer. Med Oncol (2013) 1.03
Expression of nuclear Notch3 in pancreatic adenocarcinomas is associated with adverse clinical features, and correlates with the expression of STAT3 and phosphorylated Akt. J Surg Oncol (2008) 1.01
Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression. Histopathology (2012) 1.00
Notch3 functions as a tumor suppressor by controlling cellular senescence. Cancer Res (2013) 0.98
Defining NOTCH3 target genes in ovarian cancer. Cancer Res (2012) 0.97
Prognostic significance of Notch signalling molecules and their involvement in the invasiveness of endometrial carcinoma cells. Histopathology (2012) 0.94
Notch3 is activated by chronic hypoxia and contributes to the progression of human prostate cancer. Int J Cancer (2013) 0.94
Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer. Am J Clin Pathol (2012) 0.91
Adjuvant therapy in non-small cell lung cancer: current and future directions. Oncologist (2010) 0.88
Molecular pathogenesis of early-stage non-small cell lung cancer and a proposal for tissue banking to facilitate identification of new biomarkers. J Thorac Oncol (2007) 0.86
Dll4-Notch signaling in regulation of tumor angiogenesis. J Cancer Res Clin Oncol (2013) 0.86
Notch1 is a 5-fluorouracil resistant and poor survival marker in human esophagus squamous cell carcinomas. PLoS One (2013) 0.85
Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma. Clin Cancer Res (2012) 0.84
Down-regulated expression of Notch signaling molecules in human endometrial cancer. Med Oncol (2013) 0.84
Clinical implications of DLL4 expression in gastric cancer. J Exp Clin Cancer Res (2013) 0.84
High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC). Angiogenesis (2012) 0.80
Notch1 signaling pathway participates in cancer invasion by regulating MMPs in lingual squamous cell carcinoma. Oncol Rep (2011) 0.80